SCHEMBL6589702

SCHEMBL6589702

CCC(=O)Oc1c(C)c(-c2cc3ccccc3o2)oc(=O)c1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 3/20 0.43
MAPT P10636 3/20 0.42
TP53 P04637 1/20 0.42
CASP3 P42574 1/20 0.42
SENP8 Q96LD8 1/20 0.42
SENP7 Q9BQF6 1/20 0.42
SENP6 Q9GZR1 1/20 0.42
KDM4E B2RXH2 6/20 0.41
ALDH1A1 P00352 5/20 0.41
POLB P06746 2/20 0.41
LMNA P02545 1/20 0.41
CYP3A4 P08684 1/20 0.40
CD74 P04233 1/20 0.40
MIF P14174 1/20 0.40
HPGD P15428 2/20 0.40
JAK2 O60674 1/20 0.39
JAK3 P52333 1/20 0.39
CA12 O43570 1/20 0.39
CYP1A2 P05177 1/20 0.39
NT5E P21589 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6596132 0.90 MAPT (0.40) MAOBMAPTTP53CASP3SENP8
Hydrochloric Acid SCHEMBL6589959 0.89 MAPT (0.39) MAOBMAPTTP53CASP3SENP8
SCHEMBL6590268 0.89 KDM4E (0.41) MAOBMAPTTP53CASP3SENP8
SCHEMBL6593717 0.88 SMN1; SMN2 (0.45) MAOBMAPTTP53CASP3SENP8
SCHEMBL6597439 0.88 MAOB (0.41) MAOBMAPTTP53CASP3SENP8
SCHEMBL6595001 0.87 CD74 (0.49) MAOBMAPTCASP3KDM4EALDH1A1
SCHEMBL6589965 0.86 KDM4E (0.46) MAOBMAPTKDM4EALDH1A1POLB
SCHEMBL6591522 0.86 NPC1 (0.41) MAOBMAPTKDM4EALDH1A1LMNA
SCHEMBL6592152 0.86 RAB9A (0.38) MAOBMAPTTP53CASP3SENP8
SCHEMBL6590198 0.86 MAPT (0.39) MAOBMAPTTP53CASP3SENP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1063235-B1 BENZOFURYLPYRONE DERIVATIVES TEIJIN LTD (JP) 2004-05-12 EP disclosed
US-20030186976-A1 Benzofurylpyrone derivatives TEIJIN LIMITED, MICROBIAL CHEMISTRY RESEARCH FOUNDATION 2003-10-02 US disclosed
US-6589984-B1 Blood cholesterol and triglycerides (TG) themselves are generally insoluble in blood, and they exist as lipoproteins by binding with apolipoproteins. In the body, triglycerides are biosynthesized primarily in the liver from acetyl CoA as TEIJIN LIMITED (JP) 2003-07-08 US disclosed
CN-1299359-A Benzofurylpyrone derivatives TEIJIN LTD (JP) 2001-06-13 CN disclosed
EP-1063235-A1 BENZOFURYLPYRONE DERIVATIVES TEIJIN LIMITED (JP) 2000-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030186976-A1 Benzofurylpyrone derivatives PLIN5, ACSL5, PLIN1 MAOB 3367/4885MAPT 3955/4885TP53 4084/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.